P1Y 0001970743 false Q2 --12-31 0001970743 2026-04-01 2026-06-30 0001970743 us-gaap:SubsequentEventMember 2026-07-24 2026-07-24 0001970743 us-gaap:SubsequentEventMember us-gaap:WarrantMember 2026-07-22 0001970743 us-gaap:WarrantMember 2026-07-22 0001970743 us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 0001970743 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-07-22 0001970743 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember 2026-07-22 0001970743 2026-01-01 2026-06-30 0001970743 rmx:DerivativeLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001970743 rmx:DerivativeLiabilitiesMember srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001970743 rmx:DerivativeLiabilitiesMember 2026-06-30 0001970743 us-gaap:MeasurementInputSharePriceMember 2026-06-30 0001970743 2026-06-30 0001970743 rmx:DerivativeLiabilitiesMember 2026-01-01 2026-06-30 0001970743 rmx:DerivativeLiabilitiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-12-31 0001970743 srt:MaximumMember rmx:DerivativeLiabilitiesMember us-gaap:MeasurementInputPriceVolatilityMember 2025-12-31 0001970743 rmx:DerivativeLiabilitiesMember 2025-12-31 0001970743 rmx:DerivativeLiabilitiesMember us-gaap:MeasurementInputSharePriceMember 2025-12-31 0001970743 2025-12-31 0001970743 us-gaap:CommonClassAMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassAMember 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-06-30 0001970743 us-gaap:CommonClassAMember rmx:UnsecuredPromissoryNoteMember 2026-01-01 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:DecemberThirtyFirstTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:DecemberThirtyFirstTwoThousandTwentySixMember 2026-12-31 2026-12-31 0001970743 rmx:PromissoryNotesMember rmx:MayThirtyTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:AugustThirtyFirstTwoThousandTwentySixMember 2026-08-31 2026-08-31 0001970743 rmx:ConvertibleNotesMember rmx:MayThirtyTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:ConvertibleNotesMember rmx:AugustThirtyFirstTwoThousandTwentySixMember 2026-08-31 2026-08-31 0001970743 rmx:PromissoryNotesMember rmx:JuneThirtyTwoThousandTwentySixMember 2025-12-31 0001970743 rmx:PromissoryNotesMember rmx:JuneThirtyTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:JuneThirtyTwoThousandTwentySixMember 2026-06-30 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:AprilThirtyTwoThousandTwentySixMember 2025-12-31 0001970743 rmx:PromissoryNotesMember rmx:AprilThirtyTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:AprilThirtyTwoThousandTwentySixMember 2026-04-30 2026-04-30 0001970743 rmx:PromissoryNotesMember 2026-06-30 0001970743 rmx:PromissoryNotesMember 2026-06-30 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:JanuaryThirtyFirstTwoThousandTwentySixMember 2025-12-31 0001970743 rmx:PromissoryNotesMember rmx:JanuaryThirtyFirstTwoThousandTwentySixMember 2026-01-31 2026-01-31 0001970743 rmx:PromissoryNotesMember rmx:MarchThirtyFirstTwoThousandTwentySixMember 2025-12-31 0001970743 rmx:PromissoryNotesMember rmx:MarchThirtyFirstTwoThousandTwentySixMember 2026-08-31 2026-08-31 0001970743 rmx:ConvertibleNotesMember rmx:MarchThirtyFirstTwoThousandTwentySixMember 2025-12-31 0001970743 rmx:ConvertibleNotesMember rmx:MarchThirtyFirstTwoThousandTwentySixMember 2026-03-31 2026-03-31 0001970743 srt:MaximumMember 2026-06-30 0001970743 srt:MinimumMember 2026-06-30 0001970743 us-gaap:WarrantMember 2026-06-30 0001970743 2025-01-01 2025-12-31 0001970743 us-gaap:BlackScholesMertonModelMember 2026-01-01 2026-06-30 0001970743 us-gaap:BlackScholesMertonModelMember 2026-06-30 0001970743 srt:MaximumMember us-gaap:BlackScholesMertonModelMember 2026-06-30 0001970743 srt:MinimumMember us-gaap:BlackScholesMertonModelMember 2026-06-30 0001970743 us-gaap:WarrantMember us-gaap:BlackScholesMertonModelMember 2026-01-01 2026-06-30 0001970743 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001970743 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-06-30 0001970743 us-gaap:PrivatePlacementMember 2026-01-01 2026-06-30 0001970743 srt:MaximumMember us-gaap:WarrantMember 2026-06-30 0001970743 srt:MinimumMember us-gaap:WarrantMember 2026-06-30 0001970743 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001970743 us-gaap:EmployeeStockOptionMember 2026-06-30 0001970743 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-06-30 0001970743 rmx:SeriesXPreferredStockMember 2025-12-31 0001970743 rmx:SeriesXPreferredStockMember 2026-06-30 0001970743 rmx:SeriesXPreferredStockMember 2026-03-31 0001970743 rmx:SeriesXPreferredStockMember 2026-01-01 2026-03-31 0001970743 2026-10-13 2026-10-13 0001970743 rmx:ClassBCommonStockToClassACommonStockMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:IntellectualPropertyMember 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:IntellectualPropertyMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassBMember 2025-12-31 0001970743 us-gaap:CommonClassBMember 2026-06-30 0001970743 us-gaap:CommonClassBMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassAMember 2025-12-31 0001970743 us-gaap:CommonStockMember 2025-12-31 0001970743 us-gaap:CommonStockMember 2026-06-30 0001970743 rmx:BevilacquaPLLCMember 2026-01-01 2026-06-30 0001970743 2025-04-15 0001970743 rmx:RMXIndustriesIncMember 2025-04-15 0001970743 rmx:TXSubMember 2025-04-15 0001970743 us-gaap:CommonClassAMember 2025-04-15 2025-04-15 0001970743 2025-01-01 2025-06-30 0001970743 rmx:VSDDSemaphoreXAIMeetingAgentAndInfrastructureMember 2026-06-30 0001970743 us-gaap:CommonClassAMember rmx:VSDDSemaphoreXAIMeetingAgentAndInfrastructureMember 2026-05-08 0001970743 us-gaap:CommonClassAMember rmx:VSDDSemaphoreXAIMeetingAgentAndInfrastructureMember 2026-05-08 2026-05-08 0001970743 us-gaap:PatentsMember 2026-06-30 0001970743 us-gaap:PatentsMember 2023-07-31 2023-07-31 0001970743 us-gaap:PatentsMember 2016-09-20 0001970743 2025-04-01 2025-06-30 0001970743 us-gaap:ComputerEquipmentMember 2025-12-31 0001970743 us-gaap:ComputerEquipmentMember 2026-06-30 0001970743 2025-06-30 0001970743 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2026-06-30 0001970743 rmx:ManagementsPlansMember 2026-01-01 2026-06-30 0001970743 rmx:ManagementsPlansMember 2026-06-30 0001970743 srt:MaximumMember us-gaap:CommonClassBMember 2026-07-22 2026-07-22 0001970743 srt:MinimumMember us-gaap:CommonClassBMember 2026-07-22 2026-07-22 0001970743 us-gaap:CommonClassAMember srt:MaximumMember us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 0001970743 us-gaap:CommonClassAMember srt:MinimumMember us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 0001970743 us-gaap:SubsequentEventMember us-gaap:CommonClassBMember 2026-07-22 2026-07-22 0001970743 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 0001970743 us-gaap:SubsequentEventMember 2026-07-22 0001970743 rmx:ReverseStockSplitMember us-gaap:SubsequentEventMember us-gaap:CommonClassBMember 2026-07-22 2026-07-22 0001970743 us-gaap:CommonClassAMember rmx:ReverseStockSplitMember us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 0001970743 rmx:ReverseStockSplitMember us-gaap:SubsequentEventMember 2026-07-22 0001970743 us-gaap:SubsequentEventMember us-gaap:CommonClassBMember 2026-07-22 0001970743 2024-12-31 0001970743 us-gaap:RetainedEarningsMember 2026-06-30 0001970743 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001970743 us-gaap:PreferredStockMember 2026-06-30 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-06-30 0001970743 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0001970743 us-gaap:PreferredStockMember 2026-01-01 2026-06-30 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001970743 us-gaap:RetainedEarningsMember 2026-01-01 2026-06-30 0001970743 us-gaap:RetainedEarningsMember 2025-12-31 0001970743 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001970743 us-gaap:PreferredStockMember 2025-12-31 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-12-31 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-12-31 0001970743 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001970743 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001970743 2026-03-31 0001970743 us-gaap:RetainedEarningsMember 2026-03-31 0001970743 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001970743 us-gaap:PreferredStockMember 2026-03-31 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-03-31 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-03-31 0001970743 us-gaap:RetainedEarningsMember 2025-06-30 0001970743 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-06-30 0001970743 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001970743 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001970743 us-gaap:RetainedEarningsMember 2024-12-31 0001970743 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0001970743 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001970743 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001970743 2025-03-31 0001970743 us-gaap:RetainedEarningsMember 2025-03-31 0001970743 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0001970743 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-03-31 0001970743 us-gaap:CommonClassBMember 2026-08-12 0001970743 us-gaap:CommonClassAMember 2026-08-12 0001970743 us-gaap:LeaseholdImprovementsMember 2026-06-30 0001970743 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001970743 rmx:PromissoryNotesMember rmx:DecemberThirtyFirstTwoThousandTwentySixMember 2025-12-31 0001970743 us-gaap:PreferredStockMember 2025-03-31 0001970743 us-gaap:PreferredStockMember 2024-12-31 0001970743 us-gaap:PreferredStockMember 2025-06-30 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001970743 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001970743 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001970743 us-gaap:PreferredStockMember 2025-01-01 2025-06-30 0001970743 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001970743 rmx:DerivativeLiabilitiesMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-12-31 0001970743 rmx:DerivativeLiabilitiesMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-06-30 0001970743 rmx:ConvertibleNotesMember rmx:MarchThirtyFirstTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:ConvertibleNotesMember rmx:MayThirtyTwoThousandTwentySixMember 2025-12-31 0001970743 rmx:PromissoryNotesMember rmx:JanuaryThirtyFirstTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:MarchThirtyFirstTwoThousandTwentySixMember 2026-06-30 0001970743 rmx:PromissoryNotesMember rmx:MayThirtyTwoThousandTwentySixMember 2025-12-31 0001970743 rmx:PromissoryNotesMember 2025-12-31 0001970743 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2026-06-30 iso4217:USD xbrli:shares xbrli:shares iso4217:USD xbrli:pure

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: June 30, 2026

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________

 

Commission File Number: 333-294940

 

RMX INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   88-2960484
(State or other jurisdiction of
incorporation or organization)
  (IRS Employer
Identification No.)
     
4514 Cole Ave, Ste. 600
Dallas, TX
  75205
(Address of principal executive offices)   (Zip Code)

 

(866) 706-4276

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes  No

 

As of August 12, 2026, there were a total of 10,015,190 shares of the registrant’s Class A Common Stock, $0.001 par value per share, outstanding, and 333,334 shares of the registrant’s Class B Common Stock, $0.001 par value per share, outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION  
   
Item 1. Financial Statements 1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 2
Item 3. Quantitative and Qualitative Disclosures About Market Risk 11
Item 4. Controls and Procedures 11
   
PART II - OTHER INFORMATION  
   
Item 1. Legal Proceedings 12
Item 1A. Risk Factors 12
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 12
Item 3. Defaults Upon Senior Securities 12
Item 4. Mine Safety Disclosures 12
Item 5. Other Information 12
Item 6. Exhibits 13
     
SIGNATURES 14

 

i

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

RMX Industries, Inc.

Unaudited Condensed Consolidated Financial Statements

 

  Page
Consolidated Balance Sheets as of June 30, 2026 (unaudited) and December 31, 2025 F-1
Consolidated Statements of Operations F-2
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) F-3
Consolidated Statements of Cash Flows F-4
Notes to the Consolidated Financial Statements F-5

 

1

 

 

RMX INDUSTRIES, INC.

Condensed Consolidated Balance Sheets

 

    As of     As of  
    June 30,     December 31,  
    2026     2025  
    (Unaudited)        
ASSETS            
Current assets:            
Cash and cash equivalents   $ 248,333     $ 109,752  
Restricted cash     1,913,320       1,913,320  
Cash, cash equivalents and restricted cash     2,161,653       2,023,072  
Accounts receivable    

28,064

      -  
Prepaid expenses     1,950       1,101  
Total current assets     2,191,667       2,024,173  
Property and equipment, net     15,067       25,998  
Goodwill and intangibles     33,588,997       30,048,702  
ROU asset, net of amortization     78,552       93,976  
Total assets   $ 35,874,283     $ 32,192,849  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                
Current liabilities:                
Accounts payable and accrued expenses   $ 1,044,126     $ 1,005,611  
Accounts payable and accrued expenses, related party     168,064       185,443  
Deferred revenue     9,128       -  
ROU, current liability     29,773       28,745  
Derivative liability     638,382       1,974,046  
Notes payable and interest (net of discount)     3,258,213       2,595,606  
Total current liabilities     5,147,686       5,789,451  
ROU, long term liability     40,579       55,855  
Deferred revenue     17,496       -  
Total long term liabilities     58,075       55,855  
Total liabilities     5,205,761       5,845,306  
Stockholders’ equity:                
Common stock Class A, $0.001 par value, 65,466,666 shares authorized; 10,015,190 and 7,380,426 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively     10,015       7,379  
Common stock Class B, $0.001 par value, 1,200,000 shares authorized; 333,334 and 666,668 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively     333       667  
Preferred stock, $0.001 par value, 10,000,000 shares authorized; 6,000 and 1,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively     6       1  
Additional paid-in capital     88,574,440       67,177,723  
Accumulated deficit     (57,916,272 )     (40,838,227 )
Total stockholders’ equity     30,668,522       26,347,543  
Total liabilities and stockholders’ equity   $ 35,874,283     $ 32,192,849  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-1

 

 

RMX INDUSTRIES, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2026     2025     2026     2025  
Revenue   $ 1,440     $ 12,592     $ 1,440     $ 38,792  
Cost of sales     -       221       -       15,371  
Gross profit     1,440       12,371       1,440       23,421  
Operating expenses:                                
General and administrative     186,767       113,198       245,675       207,628  
Payroll, compensation and benefits     840,252       1,003,689       1,262,109       1,983,251  
Professional services     1,474,296       2,013,906       1,918,842       3,234,499  
Marketing and advertising     31,444       37,364       93,467       337,794  
Research and development expense     134,527       80,030       174,127       158,319  
Total operating expenses     2,667,286       3,248,188       3,694,220       5,921,491  
Loss from operations     (2,665,846 )     (3,235,817 )     (3,692,780 )     (5,898,070 )
Other income (expense):                                
Interest income     1,011       498       1,193       1,300  
Interest expense     (185,253 )     (83,825 )     (339,394 )     (151,729 )
Change in fair value of derivative liability     1,335,664       -       1,335,664       -  
Debt discount amortization and derivative loss     (2,010,275 )     188,552       (3,962,245 )     (1,615,738 )
Loss on warrants conversion     (7,524,553 )     -       (10,420,483 )     -  
Total other income (expense)     (8,383,406 )     105,224       (13,385,265 )     (1,766,167 )
Net loss   $ (11,049,252 )   $ (3,130,592 )   $ (17,078,045 )   $ (7,664,237 )
                                 
Loss per share – basic and diluted   $ (1.25 )   $ (0.46 )   $ (2.02 )   $ (1.40 )
Weighted average number of shares outstanding – basic and diluted     8,805,678       6,750,839       8,460,544       5,482,379  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-2

 

 

RMX INDUSTRIES, INC.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Unaudited)

 

    Common Stock
Class A
    Common Stock
Class B
    Preferred Stock     Paid-in     Accumulated     Stockholders’  
    Shares     Value     Shares     Value     Shares     Value     Capital     Deficit     Equity  
Balance, March 31, 2025     3,640,284     $ 3,640       666,668     $ 667       -     $        -     $ 20,557,775     $ (21,088,287.2 )   $ (526,205 )
Net loss     -       -       -       -       -       -       -       (3,130,592.3 )     (3,130,592 )
Warrants issued for services     -       -       -       -       -       -       1,026,513       -       1,026,513  
Options issued for services     -       -       -       -       -       -       633,212       -       633,212  
Acquisition of business and assets     2,851,798       2,852       -       -       -       -       29,941,024       -       29,943,876  
Common stock issued for services     100,900       101       -       -       -       -       323,915       (45 )     323,970  
Balance, June 30, 2025     6,592,982     $ 6,593       666,668     $ 667       -     $ -     $ 52,482,438     $ (24,218,924 )   $ 28,270,774  
                                                                         
Balance, December 31, 2024     3,493,144     $ 3,493       666,668     $ 667       -     $ -     $ 16,241,924     $ (16,554,687 )   $ (308,603 )
Net loss     -       -       -       -       -       -       -       (7,664,237 )     (7,664,237 )
Warrants issued for services     -       -       -       -       -       -       1,935,364       -       1,935,364  
Warrants issued for notes payable     -       -       -       -       -       -       1,900,000       -       1,900,000  
Common stock issued for cash     13,283       13       -       -       -       -       127,919       -       127,932  
Options issued for services     -       -       -       -       -       -       1,207,169       -       1,207,169  
Acquisition of business and assets     2,851,798       2,852       -       -       -       -       29,941,024       -       29,943,876  
Conversion of notes payable     201,425       201       -       -       -       -       604,072       -       604,273  
Common stock issued for services     33,333       33       -       -       -       -       524,967       -       525,000  
Balance, June 30, 2025     6,592,982     $ 6,593       666,668     $ 667       -     $ -     $ 52,482,438     $ (24,218,924 )   $ 28,270,774  
                                                                         
Balance, March 31, 2026     7,568,963     $ 7,569       666,668     $ 667       6,000     $ 6     $ 69,870,046     $ (46,867,022 )   $ 23,011,266  
Net loss     -       -       -       -       -       -       -       (11,049,250 )     (11,049,250 )
Warrants issued for services     -       -       -       -       -       -       899,564       -       899,564  
Warrants issued for notes payable     -       -       -       -       -       -       1,410,000       -       1,410,000  
Options issued for services     -       -       -       -       -       -       649,416       -       649,416  
Conversion of common stock     333,334       333       (333,334 )     (333 )     -       -       -       -       -  
Acquisition of business and assets     500,000       500       -       -       -       -       3,651,850       -       3,652,350  
Conversion of notes payable     1,612,894       1,613       -       -       -       -       12,093,563       -       12,095,176  
Balance, June 30, 2026     10,015,190     $ 10,015       333,334     $ 333       6,000     $ 6     $ 88,574,440     $ (57,916,272 )   $ 30,668,522  
                                                                         
Balance, December 31, 2025     7,380,426     $ 7,380       666,668     $ 667       1,000     $ 1     $ 67,177,723     $ (40,838,227 )   $ 26,347,543  
Net loss     -       -       -       -       -       -       -       (17,078,045 )     (17,078,045 )
Warrants issued for services     -       -       -       -       -       -       906,813       -       906,813  
Warrants issued for notes payable     -       -       -       -       -       -       1,980,000       -       1,980,000  
Warrants issued for services     -       -       -       -       -       -       765,792       -       765,792  
Conversion of common stock     333,334       333       (333,334 )     (333 )     -       -       -       -       -  
Common stock issued for services     4,167       4       -       -       5,000       5       62,991       -       63,001  
Acquisition of business and assets     500,000       500       -       -       -       -       3,651,850       -       3,652,350  
Conversion of notes payable     1,797,264       1,797       -       -       -       -       14,029,271       -       14,031,068  
Balance, June 30, 2026     10,015,190     $ 10,015       333,334     $ 333       6,000     $ 6     $ 88,574,440     $ (57,916,272 )   $ 30,668,522  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-3

 

 

RMX INDUSTRIES, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

    Six Months Ended  
    June 30,  
    2026     2025  
Cash flows from operating activities of continuing operations:            
Net loss   $ (17,078,045 )   $ (7,664,237 )
Adjustments to reconcile net loss to cash used in operating activities:                
Stock issued for services     63,000       525,000  
Options issued for services     765,792       1,207,169  
Warrants issued for private placements fees     906,813       1,935,364  
Depreciation and amortization     122,945       30,725  
Loss on conversion of notes payable     10,420,483       -  
Notes payable discount amortization     3,962,244       1,615,738  
Derivative liability gain and loss     (1,335,664 )     -  
Changes in operating assets and liabilities:                
Accounts receivable     (28,064 )     -  
Deferred revenue     26,624       -  
Prepaid expenses     (849 )     15,211  
ROU asset, net     15,424       -  
Accounts payable and accrued expenses     21,180       (95,595 )
ROU liabilities     (14,249 )     -  
Interest payable     339,394       151,729  
Net cash used in operating activities     (1,812,972 )     (2,278,896 )
                 
Cash flows from investing activities:                
Net cash used in investing activities     -       -  
                 
Cash flows from financing activities:                
Proceeds from notes payable     1,980,000       1,900,000  
Payment of notes payable     (28,447 )     -  
Proceeds from the sale of common stock     -       127,932  
Net cash provided by financing activities     1,951,553       2,027,932  
                 
Net change in cash and cash equivalents     138,581       (250,964 )
Cash, cash equivalents and restricted cash at beginning of period     2,023,072       396,870  
Cash, cash equivalents and restricted cash at end of period   $ 2,161,653     $ 145,906  
Supplemental disclosure of cash flow information:                
Acquisition of business and assets   $ 3,652,350     $ 29,943,876  
Conversion of notes payable into common stock   $ 3,610,585     $ 604,273  

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-4

 

 

RMX INDUSTRIES, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1. NATURE OF OPERATIONS

 

RMX Industries, Inc. (formerly Reticulate Micro, Inc.) was incorporated on June 23, 2022, in Nevada and changed its name to RMX Industries, Inc. (“RMX” or the “Company”) on August 1, 2025. The Company maintains offices in Dallas and Leander, Texas.

 

RMX is a technology company focused on building intelligence architecture for real-world physical environments where operational data is created, decisions need to be made, and reliance on centralized cloud processing alone is not sufficient. The Company refers to this focus as physical-edge intelligence.

 

The Company’s foundational technology originated in high-efficiency video compression and transport, developed under the Video Adaptive Systems Technology (VAST™) platform. VAST was originally built to move high-quality video across constrained, low-bandwidth networks — an environment that required extreme efficiency, resilience, and edge-side operation. Building on that provenance, the Company has evolved from a video compression company into a physical-edge intelligence company, delivered through its proprietary platform, QuantrusX™. QuantrusX incorporates VAST as an underlying video and data-transport capability rather than as a separately marketed product line, alongside proprietary internal intelligence capabilities that support model refinement and lower-latency reasoning at the edge. In June 2026, the Company commenced its inaugural QuantrusX deployment at a training and operations facility in Texas, generating the Company’s first commercial platform revenue.

 

In 2024, the Company achieved quotation on the OTCQB® Venture Market of OTC Markets Group, Inc. under the symbol “RMXI,” with trading beginning in January 2025. The Company is preparing for a planned senior exchange uplisting.

 

Reverse Stock Split

 

On July 22, 2026, the Company filed with the Secretary of State of the State of Nevada a Certificate of Change, pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding shares of class A common stock, $0.001 par value per share (the “Class A Common Stock”), and class B common stock, $0.001 par value per share (the “Class B Common Stock”). The Reverse Split was effective as of 5:00 p.m. Eastern Time on July 24, 2026. Pursuant to the Nevada Revised Statutes 78.207, a company’s board of directors has the authority to effect a reverse stock split without stockholder approval if the number of authorized shares of common stock and the number of outstanding shares of common stock are proportionally reduced.

 

Prior to the Reverse Split, the Company was authorized to issue 200,000,000 shares of common stock, consisting of 196,400,000 shares of Class A Common Stock and 3,600,000 shares of Class B Common Stock. As a result of the Reverse Split, each three (3) pre-split shares of Class A Common Stock or Class B Common Stock outstanding were automatically combined into one (1) new share of Class A Common Stock or Class B Common Stock, respectively, without any action on the part of the holders, and the Company is now authorized to issue 66,666,666 shares of common stock, consisting of 65,466,666 shares of Class A Common Stock and 1,200,000 shares of Class B Common Stock. The number of shares of preferred stock that the Company is authorized to issue was not impacted. As a result of the Reverse Split, the number of outstanding shares of Class A Common Stock was reduced from 30,045,216 to approximately 10,015,190 and the number of outstanding shares of Class B Common Stock was reduced from 1,000,000 to approximately 333,334.

 

All share and per share information in these unaudited condensed consolidated financial statements (“financial statements”) retroactively reflect this reverse stock split.

 

F-5

 

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

 

Since inception, the Company has incurred losses, resulting in an accumulated deficit of $57,916,272 as of June 30, 2026, with further losses expected as it continues to develop its business. For the six months ended June 30, 2026, the Company used $1,812,972 in cash for operating activities. As of June 30, 2026, the Company had $2,161,653 in cash and cash equivalents, including $1,913,320 of restricted cash. The Company estimates that it will require approximately $4.0 million to fund operations for the twelve months following the issuance of these financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the financial statements are issued.

 

Management’s Plans

 

The Company has applied for an uplisting of its Class A Common Stock on NYSE American. Upon approval of such uplisting, a total of approximately $5.0 million will become available to the Company, consisting of (i) the release of the $1.9 million of restricted cash currently reflected on the Company’s balance sheet, and (ii) an approximate $3.0 million deposit to be made by an institutional investor (the “Investor”) pursuant to the executed securities purchase agreement between the Company and the Investor. Of the approximately $5.0 million, approximately $3.0 million will be immediately unrestricted and available for general corporate purposes, with the remainder becoming available upon satisfaction of the conditions set forth in the Investor agreements. In addition, the Company maintains a contingent financing facility with the Investor providing for up to $45.0 million of additional financing (the “Credit Facility”), pursuant to the securities purchase agreement and subject to the terms and conditions thereof, which management believes would be available to fund any shortfall in the Company’s working capital requirements.

 

In June 2026, the Company commenced commercial deployment of its QuantrusX edge intelligence platform. The Company’s commercial model provides for fixed-fee, prepaid multi-year subscription arrangements, under which contract consideration is collected at or near contract inception and recognized as revenue ratably over the subscription term. Accordingly, executed customer agreements generate cash proceeds in advance of revenue recognition. The Company executed its initial multi-year prepaid QuantrusX subscription agreement in June 2026 and maintains an active pipeline of prospective customers, which management expects to contribute to liquidity over the next twelve months.

 

The amounts becoming available upon uplisting are conditioned upon approval of the Company’s NYSE American listing application, which is not within the Company’s control, and availability under the Credit Facility is subject to conditions that may not be satisfied. There can be no assurance that the Company’s listing application will be approved, that amounts under the Credit Facility will be available when needed or on acceptable terms, or as to the timing or volume of future customer agreements. Accordingly, management has concluded that these plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis of Presentation

 

The accompanying financial statements of the Company are expressed in United States dollars and are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company has adopted a December 31 fiscal year end.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

 

F-6

 

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market funds, the fair value of which approximates cost. The Company maintains its cash balances with a high-credit-quality financial institution. At times, such cash may be more than the Federal Deposit Insurance Corporation-insured limit of $250,000. The Company has not experienced any losses in such accounts, and management believes the Company is not exposed to any significant credit risk on its cash and cash equivalents.

 

Fair Value Measurements

 

FASB ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable.

 

Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2026 and 2025. The Company uses the market approach to measure fair value for its Level 1 financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The respective carrying value of certain balance sheet financial instruments approximates its fair value. These financial instruments include cash, accounts payable, and accrued liabilities. Fair values were estimated to approximate carrying values for these financial instruments since they are short term in nature, and they are receivable or payable on demand.

 

The estimated fair value of assets and liabilities acquired in business combinations and reporting units and long-lived assets used in the related asset impairment tests utilize inputs classified as Level 3 in the fair value hierarchy.

 

Research and Development

 

Research and development costs are expensed as incurred. For the three months ended June 30, 2026 and 2025, research and development expense was $134,527 and $80,030, respectively. For the six months ended June 30, 2026 and 2025, research and development expense was $174,127 and $158,319, respectively.

 

Share-Based Compensation

 

ASC 718, “Compensation – Stock Compensation”, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their grant date fair values. That expense is recognized over the period when an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period) or the straight-line attribution method.

 

F-7

 

 

Under 718-10-30-20D the determination of whether a valuation method is reasonable, or whether an application of a valuation method is reasonable, shall be made based on the facts and circumstances as of the measurement date. Factors to be considered under a reasonable valuation method include, as applicable:

 

  a. The value of tangible and intangible assets of the nonpublic entity

 

  b. The present value of anticipated future cash flows of the nonpublic entity

 

  c. The market value of stock or equity interests in similar corporations and other entities engaged in trades or businesses substantially similar to those engaged in by the nonpublic entity for which the stock is to be valued, the value of which can be readily determined through nondiscretionary, objective means (such as through trading prices on an established securities market or an amount paid in an arm’s-length private transaction)

 

Share-based compensation expense for the three and six months ended June 30, 2026 and 2025 was as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2026     2025     2026     2025  
Issuance of options for services     649,416       633,212       765,792       1,207,169  
Issuance of shares for services     -       525,000       63,000       525,000  
Issuance of warrants for services     899,564       1,026,513       906,813       1,935,364  

 

Basic and Diluted Net Income (Loss) Per Share

 

The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common stock outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

 

Revenue Recognition

 

The Company has adopted revenue recognition policies for its principal revenue types, including subscription and license fees, usage-based fees, professional and other services, and hardware. Prior to fiscal year 2026, the Company's revenue was derived from software license, hardware, and professional services activity. Beginning in the second quarter of 2026, the Company introduced QuantrusX, an edge intelligence platform, and revenue has since primarily consisted of QuantrusX subscription fees; other revenue streams described below have not been material during the periods presented.

 

QuantrusX — Edge Intelligence Platform. During the second quarter of 2026, the Company introduced QuantrusX, an edge intelligence platform designed to bring computation, data interpretation, and decision support closer to the physical edge, where data is created and decisions must be made in real time. QuantrusX incorporates proprietary internal intelligence capabilities that support model refinement, governed learning from field inputs, and lower-latency reasoning within the platform environment. These internal capabilities are not sold as standalone customer products. In June 2026, the Company moved QuantrusX into its first commercial deployment, representing the Company’s initial transition of the platform from development to a revenue-generating, in-field deployment.

 

Inferencing and Usage-Based Fees. As part of its QuantrusX commercial model, the Company earns usage-based fees tied to the volume of inferences processed and computational usage of the platform as it interprets field data and generates decision support in real time. These fees are billed based on customer consumption during the period and revenue is recognized under the Company’s variable consideration policy as the underlying usage occurs, consistent with ASC 606’s guidance on usage-based royalties and consumption-based pricing. Because inferencing volume can fluctuate with deployment activity and field conditions, revenue from this stream may vary period to period as QuantrusX scales across additional sites and customers.

 

F-8

 

 

Software license and subscription revenues include software license revenues from the sales of software licenses and subscription fees from customers accessing the Company’s services. Revenue is recognized upon transfer of control of promised products and services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. If the consideration promised in a contract includes a variable amount, for example, overage fees, contingent fees or service level penalties, the Company includes an estimate of the amount it expects to receive for the total transaction price if it is probable that a significant reversal of cumulative revenue recognized will not occur.

 

The Company determines the amount of revenue to be recognized through the application of the following steps:

 

identification of the contract, or contracts, with a customer;

 

identification of the performance obligations in the contract;

 

determination of the transaction price;

 

allocation of the transaction price to the performance obligations in the contract; and

 

recognition of revenue when or as the Company satisfies the performance obligations.

 

Professional Services and Other Revenues. The Company’s professional services contracts are either on a time and materials, fixed price or subscription basis. These revenues are recognized as the services are rendered for time and materials contracts, on a proportional performance basis for fixed price contracts or ratably over the contract term for subscription professional services contracts. Other revenues consist primarily of training revenues recognized as such services are performed.

 

Hardware. Our hardware is generally highly dependent on, and interrelated with, the underlying operating system and cannot function without the operating system. In these cases, the hardware and software license are accounted for as a single performance obligation and revenue is recognized at the point in time when ownership is transferred to resellers or directly to end customers through retail stores and online marketplaces.

 

Property and Equipment

 

Property and equipment over $2,500 are stated at cost less accumulated depreciation, and depreciated using the straight-line method over the shorter of the estimated useful life of the asset or the lease term. The estimated useful lives of our property and equipment are generally as follows: computer software developed or acquired for internal use, three years; computer equipment, three to five years; leasehold improvements, shorter of lease term or estimated useful life; and furniture and equipment, one to 10 years.

 

3. REVENUES

 

Revenue is attributed to the region of the contracting entity, which may differ from the customer’s location. All revenue attributed to the Americas was generated in the United States. Revenue was $1,440 and $12,592 for the three months ended June 30, 2026 and 2025, respectively, and $1,440 and $38,792 for the six months ended June 30, 2026 and 2025, respectively.

 

Deferred Revenue

 

Deferred revenue represents amounts invoiced or received from customers in advance of the Company satisfying its related performance obligations under ASC 606, Revenue from Contracts with Customers. Deferred revenue is recognized as revenue as the Company transfers control of the promised products or services to the customer. The current portion of deferred revenue represents amounts expected to be recognized as revenue within twelve months of the balance sheet date; the long-term portion represents amounts expected to be recognized beyond twelve months, based on the performance and delivery terms of the underlying contracts. Short-term deferred revenue totaled $9,128 and $0 respectively as of June 30, 2026 and 2025. Long-term deferred revenue totaled $17,496 and $0 as of June 30, 2026 and 2025 respectively.

 

4. PREPAID EXPENSES

 

As of June 30, 2026 and 2025, the prepaid balance was $1,950 and $1,101 respectively. Expenses were primarily due to timing of operational cost recognition.

 

F-9

 

 

5. PROPERTY AND EQUIPMENT

 

    As of     As of  
    June 30,     December 31,  
    2026     2025  
Computers, equipment and software   $ 65,339     $ 65,339  
Leasehold improvements     -       -  
Property and equipment gross     65,339       65,339  
Less accumulated depreciation and amortization     (50,272 )     (39,341 )
Property and equipment, net   $ 15,067     $ 25,998  

 

Depreciation and amortization expense totaled $107,626 and $15,407 for the three months ended June 30, 2026 and 2025, respectively, and $122,945 and $30,725 for the six months ended June 30, 2026 and 2025, respectively.

 

6. INTANGIBLE ASSET – PROPERTY LICENSE

 

    As of     As of  
    June 30,     December 31,  
    2026     2025  
Intangibles (net of amortization)   $ 3,645,121     $ 104,826  

 

On March 14, 2023, the Company entered into an intellectual property purchase agreement with Basestones Capital Ltd., for the purchase of US Patent No. 9,451,291 (Fast DWT-Based Intermediate Codec Optimized For Massively Parallel Architecture), issued on September 20, 2016, and the developed source code related to the patent. The Company made a one-time payment of $200,000 for the patent. The Company recorded $205,100 as an intangible asset. Starting in July 2023, the Company began amortizing the $200,000 intangible assets. As of June 30, 2026, the Company recorded $120,110 of accumulated depreciation.

 

On May 8, 2026, the Company entered into an intellectual property purchase agreement with Apollo Group Enterprises, LLC, pursuant to which the Company acquired two software platforms 1) ODIN, AI video intelligence/surveillance system and 2) VSDD/Semaphore-X, AI meeting agent and infrastructure — plus related trade secrets, know-how, and data assets, paying 500,000 shares of Class A Common Stock valued at $3,652,350 ($7.30 per share). The acquired assets do not meet the definition of a business because no organized workforce or other substantive process was acquired. Accordingly, the transaction is accounted for as an asset acquisition. The full transaction cost is capitalized to the single software intangible asset at cost, with no goodwill recognized. As of June 30, 2026, the Company recorded $88,057 accumulated amortization.

 

The Company evaluates the recoverability of long-lived assets whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable. Such circumstances could include, but are not limited to, (1) a significant decrease in the market value of an asset, (2) a significant adverse change in the extent or manner in which an asset is used, or (3) an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. The Company compares the carrying amount of the asset against the estimated undiscounted future cash flows associated with it. Should the sum of the expected future net cash flow be less than the carrying value of the asset being evaluated, an impairment loss would be recognized. The impairment loss would be calculated as the amount by which the carrying value of the asset exceeds its estimated fair value. Impairment loss on long-lived assets for six months ended June 30, 2026, and 2025 was $0.

 

7. BUSINESS COMBINATION AND GOODWILL

 

On April 15, 2025, the Company completed the acquisition of RMX Industries Inc. (“TX Sub”) and issued 2,851,798 shares of Class A Common Stock in exchange for 100% of the outstanding equity of TX Sub. The acquisition supports the Company’s strategy to commercialize and expand long-term revenue opportunities. The transaction was accounted for as a business combination under ASC 805, Business Combinations, with the Company identified as the accounting acquirer, as it issued the equity consideration, retained governance control, and its management team continued post-acquisition. The total purchase consideration was measured at fair value on the acquisition date and consisted solely of equity consideration valued at $29.9 million. As a result of the acquisition, the Company recorded goodwill of $29.9 million, representing the excess of the purchase consideration over the fair value of net identifiable assets acquired. The goodwill reflects expected future economic benefits from commercialization of the Company’s technology and anticipated synergies and market opportunities.

 

F-10

 

 

Goodwill is not deductible for income tax purposes and is assigned to the Company’s reporting unit. We test goodwill for impairment annually at the reporting unit level, primarily using a discounted cash flow methodology with a peer-based, risk-adjusted weighted average cost of capital. We believe use of a discounted cash flow approach is the most reliable indicator of the fair values of the businesses. No instances of impairment were identified in our December 31, 2025 tests.

 

8.  ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Trade payables are initially recorded at the transaction price and measured at the undiscounted expected payment amount. Accrued expenses reflect the estimated amount needed to settle obligations. Accounts payable totaled $1,044,126 as of June 30, 2026, and $1,005,611 as of December 31, 2025.

 

As of June 30, 2026, the Company owed $600,000 to Boustead Securities, LLC in connection with the termination of its prior engagement agreement. In addition, the Company owed approximately $370,000 to Bevilacqua PLLC for regulatory and corporate legal services, with the remainder owed to various vendors.

 

9. STOCKHOLDERS’ EQUITY

 

Common Stock

 

The Company is authorized to issue 65,466,666 shares of Class A Common Stock at a par value of $0.001 and had 10,015,190 and 7,380,426 shares of Class A Common Stock issued and outstanding as of June 30, 2026, and December 31, 2025, respectively.

 

The Company is authorized to issue 1,200,000 shares of Class B Common Stock at a par value of $0.001 and voting rights of 100 votes per share. The Company had 333,334 shares of Class B Common Stock issued and outstanding June 30, 2026, and 666,668 as of December 31, 2025.

 

Common Stock Issued for Services

 

The Company issued 4,167 shares of Class A Common Stock, at a price of $10.50 per share, for services provided to the Company during the six months ended June 30, 2026.

 

Common Stock Issued for Cancellation and Exchange of Notes Payable and Related Interest Through Exercise of Warrants

 

During the six months ended June 30, 2026, the Company issued 1,797,164 shares of Class A Common Stock upon the exercise of warrants in connection with the cancellation and exchange of notes and accrued interest at a weighted average price of $2.01.

 

Common Stock Issued for Purchase of Intellectual Property

 

The Company acquired intellectual property by paying 500,000 shares of Class A Common Stock valued at $3,652,350 or $7.30 per share.

 

Conversion of Class B Common Stock to Class A Common Stock

 

During the six months ended June 30, 2026, 333,334 shares of Class B Common Stock were converted into shares of Class A Common Stock.

 

F-11

 

 

Preferred Stock

 

The Company is authorized to issue up to 10,000,000 shares of preferred stock with a par value of $0.001 per share. The Company filed a Certificate of Designation with the Secretary of State of the State of Nevada on October 13, 2025, designating 1,000 shares of the Company’s preferred stock as “Series X Convertible Preferred Stock” (the “Series X Preferred Stock”) and setting forth the voting and other powers, preferences and relative, participating, optional or other rights of the Series X Preferred Stock. Each share of Series X Preferred Stock has an initial stated value of $3.85 per share. On March 31, 2026, the Company filed a Certificate of Amendment to Designation with the Secretary of State of the State of Nevada increasing the designated shares of Series X Preferred Stock to 6,000. Additionally, on March 31, 2026, the Company issued 5,000 shares of Series X Preferred Stock to Karl Kit, who serves as the Company’s Chief Executive Officer, President, and member of the board of directors. Each share of Series X Preferred Stock is convertible into one (1) share of Class A Common Stock and entitles the holder to 15,000 votes per share. The Company had 6,000 and 1,000 shares of Series X Preferred Stock issued and outstanding as of June 30, 2026, and December 31, 2025, respectively.

 

Options

 

During the six months ended June 30, 2026, the Company issued 333,334 stock options with weighted average strike price of $7.48.

 

Of the 1,662,577 options outstanding as of June 30, 2026, 333,334 options will only vest upon listing on any national securities exchange. This performance condition is not considered probable until it occurs. As such, the expense for these awards would only be recognized upon listing on any national securities exchange. The total Black-Scholes valuation for the outstanding options as of June 30, 2026, is $2,244,350.

 

The Company recognizes compensation cost on a straight-line basis over the total requisite service period of the entire award and accounts for forfeitures as they occur. Total expenses of $649,416 and $765,792 were recognized during the three months and six months ended June 30, 2026, respectively.

 

The following table reflects a summary of Class A Common Stock options outstanding and option activity during the six months ended June 30, 2026:

 

    Underlying
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Terms
(Years)
 
Options outstanding at December 31, 2025     1,768,345     $ 5.61       8.4  
Granted     333,334       7.48       -  
Exercised     -       -       -  
Forfeited     (321,878 )     -       -  
Cancelled     (117,224 )     -       -  
Options outstanding at June 30, 2026     1,662,577     $ 7.46       8.4  
Options exercisable at June 30, 2026     839,970       6.84       7.9  

 

The intrinsic value of options outstanding as of June 30, 2026, was $1,411,285.

 

Warrants

 

During the six months ended June 30, 2026, the Company issued a total of 1,474,932 warrants at a weighted average exercise price of $1.70 with a range between $1.50 and $5.40 per share, which vested immediately.

 

The Company conducted private placements of units, with each unit consisting of an unsecured promissory note with an interest rate of 18% and a five-year warrant to purchase shares of Class A Common Stock, with a number of investors. The Company raised $1,980,000 and issued 1,320,024 warrants with a $1.50 weighted average exercise price. The Company issued 74,074 warrants to Boustead Securities, LLC in connection with the termination of its prior engagement agreement. The remaining 80,834 warrants were issued to advisors and partners.

 

F-12

 

 

On the dates of the grants, the Company valued warrants granted at $1,088,498 using the Black-Scholes option pricing model with the following assumptions: stock price between $7.77 and $10.50 per share, an expected life of the warrants of 5 years, expected volatility of 72%, an average risk-free rate of 3.8%, and no dividend yield. The warrants were expensed at the time of issuance and an expense of $906,813 was recognized.

 

The following table reflects a summary of warrants outstanding and activity during the six months ended June 30, 2026:

 

    Underlying
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Terms
(Years)
 
Warrants outstanding at December 31, 2025     1,433,409     $ 3.44       3.87  
Granted     1,474,932       1.70       5.00  
Exercised     (1,609,195 )     -       -  
Forfeited     -       -       -  
Cancelled     -       -       -  
Warrants outstanding at June 30, 2026     1,299,146     $ 4.44       3.87  
Warrants exercisable at June 30, 2026     1,299,146       4.44       3.87  

 

The intrinsic value of warrants outstanding as of June 30, 2026, was $3,307,536.

 

10. OPERATING LEASE

 

The current lease contracts for offices in Texas have initial terms of one year. The Company leases certain vehicles under non-cancelable operating lease agreements. These leases have initial terms of three years. The Company does not have any finance leases.

 

As of June 30, 2026, the Company’s operating lease right of use assets and corresponding liabilities are as follows:

 

Right of use asset   $ 78,552  
Lease liability - current     29,773  
Lease liability - non current     40,579  
Total operating lease liabilities     70,352  
Weighted average remaining lease term     2.40  
Weighted average discount rate     7.50 %

 

Maturities of the Company’s lease liabilities are as follows:        
2026   $ 14,791  
2027     31,294  
2028     24,266  

 

F-13

 

 

11. CONVERTIBLE NOTES, PROMISSORY NOTES PAYABLE AND DEBT EXTINGUISHMENT

 

The following table summarizes outstanding convertible notes and promissory notes payable as of June 30, 2026, and December 31, 2025.

 

    June 30,     December  31,  
    2026     2025  
Convertible Notes - Maturity Date            
March 31, 2026 (15% per annum)   $ -     $ 2,020,000  
August 31, 2026 (15% per annum)     2,020,000       -  
Promissory Notes - Maturity Date                
January 31, 2026 (18% per annum)     -       550,000  
June 30, 2026 (12% per annum)     -       500,000  
April 30, 2026 (8% per annum)     -       125,000  
June 30, 2026 (12% per annum)     -       1,117,500  
August 31, 2026 (12% per annum)     75,000       -  
August 31, 2026 (18% per annum)     625,000       -  
December 31, 2026 (12% per annum)     225,000       -  
Total Notes Payable     925,000       2,292,500  
Total Convertible and Promissory Notes Payable     2,945,000       2,292,500  
Unamortized debt discount     -       (1,982,244 )
Net Debt     2,945,000       2,330,256  
Current portion     (2,945,000 )     (2,330,256 )
Net long-term portion     -       -  
Interest Payable     313,212       265,350  

 

During six months ended June 30, 2026, the Company completed private placements, raising $1,980,000 with each unit consisting of an unsecured promissory note of 18% interest and five-year warrants for Class A Common Stock; 1,320,000 warrants were issued at a weighted average exercise price of $1.50.

 

Repayment of Debt

 

During the six months ended June 30, 2026, the Company repaid $25,000 of outstanding principal and $3,447 of accrued interest on its promissory notes, for total cash payments of $28,447. These repayments reduced the Company’s outstanding notes payable balance and were made in accordance with the terms of the applicable note agreements.

 

Debt Extinguishment and Common Stock Issued

 

During the six months ended June 30, 2026, the Company converted $3,322,500 in principal and $288,085 in interest into equity through warrant exercises, issuing 1,797,164 of Class A Common Stock shares at a $1.83 average price. The Company recorded a $10,420,483 conversion loss, reflecting the difference between market value and exercise price.

 

These amounts are presented as supplemental disclosure in the “Non-Cash Investing and Financing Activities” section of the Condensed Consolidated Statement of Cash Flows.

 

The relative fair value of the warrants issued in conjunction with the notes payable was treated as a debt discount, with a corresponding offsetting credit to Additional Paid-in Capital (APIC). This discount is being amortized to interest expenses over the term of the notes.

 

Derivative Liabilities

 

The fair values of the conversion option of outstanding convertible notes payable were determined to be derivative liabilities under ASC 815 due to the default on convertible notes payable disclosed above, which resulted in a variable conversion price on the outstanding convertible note payable. The fair value of the derivative liabilities was $1,974,046 as of December 31, 2025, estimated using the Black-Scholes option pricing model with the following assumptions: stock price of $3.50 per share, an expected life of 9 months, expected volatility of 73%, an average risk-free rate of 3.5% and no dividend yield. During the six months ended June 30, 2026, the Company recorded a gain on change in fair value of derivative liability of $1,335,664, remeasuring the derivative liability to $638,382 as of June 30, 2026, using the Black-Scholes option pricing model with the following assumptions: stock price of $2.29 per share, an expected life of 2 months, expected volatility of 71.93%, an average risk-free rate of 3.71% and no dividend yield.

 

F-14

 

 

12. SUBSEQUENT EVENTS

 

On July 22, 2026, the Company conducted a closing of a private placement of units, with each unit consisting of an unsecured 18% promissory note and a five-year warrant to purchase shares of Class A Common Stock, and entered into a subscription agreement with an accredited investor as defined in Section 2(a)(15) of the Securities Act, and Rule 501 promulgated thereunder, in reliance upon the exemption contained in Section 4(a)(2) of the Securities Act, and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. Pursuant to the agreement, we sold 1 unit at a price of $25,000 per unit for gross proceeds of $25,000 and issued 16,667 warrants with an exercise price of $1.50 per share.

 

On July 24, 2026, the Company executed a one-for-three (1-for-3) reverse stock split affecting both the authorized and issued and outstanding amounts of its Class A Common Stock and Class B Common Stock. These financial statements reflect the impact of this reverse stock split.

 

F-15

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis provides information that our management believes is relevant to an assessment and understanding of the Company’s condensed consolidated results of operations and financial condition. The discussion should be read together with the unaudited condensed consolidated financial statements and the accompanying notes to those statements that are included elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements and related notes for the year ended December 31, 2025, included in our Annual Report on Form 1-K filed with the Securities and Exchange Commission (the “SEC”) on February 11, 2026. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties.

 

Use of Terms

 

Except as otherwise indicated by the context, references in this Quarterly Report on Form 10-Q to “we”, “us”, “our”, “RMX Industries”, “RMX”, “our company” and the “Company” refer to RMX Industries, Inc., a Nevada corporation, including its wholly-owned subsidiaries, EdWare LLC, a Delaware limited liability company, and RMX Industries Inc., a Texas corporation. “Class A Common Stock” refers to the Company’s Class A Common Stock, $0.001 par value per share. “Class B Common Stock” refers to the Company’s Class B Common Stock, $0.001 par value per share. “Preferred Stock” refers to the Company’s Preferred Stock, $0.001 par value per share. “Series X Preferred Stock” refers to the Company’s Series X Convertible Preferred Stock, $0.001 par value per share. Unless otherwise noted, all amounts are expressed in United States dollars (“USD”).

 

Reverse Stock Split

 

Unless otherwise noted, the share and per share information in this report have been adjusted to give effect to the one-for-three (1-for-3) reverse stock split of each of the Company’s authorized and issued and outstanding Class A Common Stock and the Company’s authorized and issued and outstanding Class B Common Stock, which became effective as of 5:00 p.m. Eastern Time on July 24, 2026 (the “Reverse Stock Split”).

 

Note Regarding Trademarks, Trade Names and Service Marks

 

We use various trademarks, trade names and service marks in our business, including “VAST™”, “QuantrusX™”, and associated marks. For convenience, we may not include the SM, ® or ™ symbols, but such omission is not meant to indicate that we would not protect our intellectual property rights to the fullest extent allowed by law. Any other trademarks, trade names or service marks referred to in this Quarterly Report on Form 10-Q are the property of their respective owners.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. All statements other than statements of historical facts are forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:

 

  our ability to successfully complete an uplisting to the NYSE American exchange;
     
  our ability to introduce new products and services;

 

our ability to obtain additional funding to develop additional products and services;

 

compliance with obligations under intellectual property licenses with third parties;

 

our ability to establish or maintain collaborations, licensing or other arrangements;

 

our ability and third parties’ abilities to protect intellectual property rights;

 

our ability to adequately support future growth;

 

our goals and strategies;

 

our future business development, financial condition and results of operations;

 

expected changes in our revenue, costs or expenditures;

 

growth of and competition trends in our industry;

 

2

 

 

the accuracy and completeness of the data underlying our or third-party sources’ industry and market analyses and projections;

 

our expectations regarding demand for, and market acceptance of, our products and services;

 

our expectations regarding our relationships with investors, institutional funding partners and other parties with whom we collaborate;

 

fluctuations in general economic and business conditions in the markets in which we operate; and

 

relevant government policies and regulations relating to our industry.

 

In some cases, you can identify these statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expects,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable expressions that convey uncertainty of future events or outcomes, although not all forward-looking statements contain these terms. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under “Risk Factors” in our Form S-1 filed with the SEC on April 9, 2026. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance.

 

In addition, statements that include terms such as “we believe” and similar terms reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this filing, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

 

Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Quarterly Report on Form 10-Q. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Overview

 

RMX operates a proprietary on-site intelligence platform for customers running physical operations who need to understand what is happening at their location as it happens. Our proprietary platform, QuantrusX™, is designed to ingest video, sensor, and access data generated at the customer’s site and turn it into a continuous, operator-usable picture of that site, delivered as a subscription service supported by Company-owned distributed data center hardware installed at each customer location. Because our platform runs on-site rather than in a remote cloud, we believe it addresses constraints that off-site systems handle poorly: bandwidth limits on transporting video and sensor data at scale, latency requirements for time-sensitive detections, and privacy and continuity expectations for information that customers prefer to keep on their own premises. We refer to the category of intelligence produced by our platform as Real-World Intelligence™, and we believe it addresses a significant and underserved need across sectors that operate physical sites at meaningful scale.

 

Our foundational technology originated in high-efficiency video compression and transport, developed under the Video Adaptive Systems Technology (VAST™) platform. VAST was originally built to move high-quality video across constrained, low-bandwidth networks — an environment that required extreme efficiency, resilience, and edge-side operation. Through extended field validation across a range of operational environments and network conditions from 2023 through 2025, VAST demonstrated the ability to deliver HD video at bandwidths as low as 200 Kbps, SD video at rates as low as 10 Kbps, direct point-to-point streaming across IP networks, and operation on low size, weight, power, and cost (SWaP-C) hardware. We believe that work established the Company’s technical provenance in edge-oriented data handling and low-latency, resource-constrained operation.

 

Building on that provenance, we have evolved from a video compression company into a Real-World Intelligence company. In May 2026, we acquired from Apollo Group Enterprises, LLC certain intellectual property assets relating to two software platforms (1) ODIN, AI video intelligence/surveillance system and (2) VSDD/Semaphore-X, AI meeting agent and infrastructure, which accelerated the development of QuantrusX and shifted our business focus from defense environments to enterprise and commercial environments. The demands that exist at the tactical edge — bandwidth scarcity, unreliable connectivity, the need for local decisioning, and the requirement to move only meaningful information back to central systems — we believe are now appearing at scale across enterprise and commercial environments as artificial intelligence (AI), computer vision, and sensor networks proliferate. Our current focus is on translating that capability into a broadly deployable enterprise and commercial platform, delivered through QuantrusX.

 

3

 

 

QuantrusX is RMX’s Real-World Intelligence platform designed to bring intelligence to the customer’s site — the campuses, facilities, and operational environments where the data is created — and to deliver that intelligence continuously. QuantrusX incorporates VAST as an underlying video and data-transport capability rather than as a separately marketed product line, alongside proprietary internal intelligence assets that support model refinement and low-latency reasoning at the site.

 

As we scale QuantrusX deployments across our customer base, they are designed to collectively form a Company-operated distributed data center — a network of computing hardware physically located at each customer’s site rather than in a remote cloud facility. We refer to the architectural layer that binds these deployments together as the “Intelligence Fabric”. Each QuantrusX deployment is expected to produce a strand of Real-World Intelligence at the customer’s location; the Intelligence Fabric is meant to weave those strands together at aggregate scale. We believe the Intelligence Fabric is more valuable than the sum of the individual strands, because it is designed to strengthen through use across the entire deployed base.

 

In June 2026, the Company completed its inaugural QuantrusX deployment at a training and operations facility in Texas, generating the Company’s first commercial platform revenue. We intend to build from that reference deployment into additional enterprise and commercial Real-World Intelligence environments.

 

In 2024, the Company achieved quotation on the OTCQB® Venture Market of OTC Markets Group, Inc. under the symbol “RMXI,” with trading beginning in January 2025. The Company is preparing for a planned senior exchange uplisting.

 

Our Historical Performance

 

As of June 30, 2026, the Company had an accumulated deficit of $57,916,272 and cash of $2,161,653 (including $1,913,320 of restricted cash). During the three months ended June 30, 2026 and 2025, we had a net loss of $11,049,252 and $3,130,592, respectively. The Company has applied for an uplisting of its Class A Common Stock on NYSE American, upon approval of which certain restricted cash and additional committed capital would become available to fund operations. In addition, the Company maintains a Credit Facility providing up to $45.0 million of additional financing, subject to the terms and conditions thereof. Management believes that these sources, together with expected cash proceeds from executed and prospective QuantrusX subscription agreements, will be sufficient to fund planned operations for at least the next twelve months. However, availability of the listing-related amounts and the Credit Facility is subject to conditions not entirely within the Company’s control, and substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. We will seek to fund our operations through public offerings, accessing the Credit Facility, private equity offerings, debt financings, and government or other third-party funding. However, the Company may not be able to raise adequate funds for capital expenditure, working capital and other cash requirements from capital markets on acceptable terms, or at all. Advances from an officer or stockholder may likewise be unavailable. The Company’s failure to raise capital as and when needed and generate significantly higher revenues than operating expenses to achieve profitability would impact its going concern status and would have a negative impact on its financial condition and its ability to pursue its business strategy and continue as a going concern. For further discussion, see “—Liquidity and Capital Resources”.

 

Recent Developments

 

On July 22, 2026, the Company conducted a closing of a private placement of units, with each unit consisting of an unsecured 18% promissory note and a five-year warrant to purchase shares of Class A Common Stock, and entered into a subscription agreement with an accredited investor as defined in Section 2(a)(15) of the Securities Act, and Rule 501 promulgated thereunder, in reliance upon the exemption contained in Section 4(a)(2) of the Securities Act, and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. Pursuant to the agreement, we sold 1 unit at a price of $25,000 per unit for gross proceeds of $25,000 and issued 16,667 warrants with an exercise price of $1.50 per share.

 

On July 24, 2026, the Company executed the Reverse Stock Split. Unless otherwise noted, the share and per share information in this report have been adjusted to give effect to the Reverse Stock Split.

 

4

 

 

Results of Operations

 

Comparison of the Three Months Ended June 30, 2026 and 2025

 

    Three Months Ended  
    June 30,  
    2026     2025  
Revenue   $ 1,440     $ 12,592  
Cost of sales     -       221  
Gross profit     1,440       12,371  
Operating expenses:                
General and administrative     2,532,759       3,168,157  
Research and development     134,527       80,030  
Total operating expenses     2,667,286       3,248,188  
Loss from operations     (2,665,846 )     (3,235,817 )
Other income (expense)     (8,383,406 )     105,224  
Net loss   $ (11,049,252 )   $ (3,130,592 )

 

Revenue

 

Our revenue was $1,440 and $12,592 for the three months ended June 30, 2026 and 2025, respectively, representing a decrease of 89%. For the three months ended June 30, 2026, revenue activity reflected the early commercialization of QuantrusX: the Company invoiced $28,064 to customers, recognized $1,440 as revenue during the period, and deferred the remaining $26,624 for future recognition ($9,128 current, $17,496 long-term) as the related performance obligations under the deployment are satisfied. For the three months ended June 30, 2025, revenue was derived from limited historical software and service activity under the Company’s prior positioning.

 

Operating Expenses

 

Our operating expenses were $2,667,286 and $3,248,188 for the three months ended June 30, 2026 and 2025, respectively, representing a decrease of 18%. The decrease was due to employee compensation including options, research and development expenses, marketing expenses and professional services provided to the Company.

 

Net Loss

 

Our net loss was $11,049,252 and $3,130,592 for the three months ended June 30, 2026 and 2025, respectively, representing an increase of 253%. The increase in net loss was mainly due to conversion of warrants, debt discount amortization, derivative expenses and loss from operations.

 

Comparison of the Six Months Ended June 30, 2026 and 2025

 

    Six Months Ended  
    June 30,  
    2026     2025  
Revenue   $ 1,440     $ 38,792  
Cost of sales     -       15,371  
Gross profit     1,440       23,421  
Operating expenses:                
General and administrative     3,520,093       5,763,172  
Research and development     174,127       158,319  
Total operating expenses     3,694,220       5,921,491  
Loss from operations     (3,692,780 )     (5,898,070 )
Other income (expense)     (13,385,265 )     (1,766,167 )
Net loss   $ (17,078,045 )   $ (7,664,237 )

 

5

 

 

Revenue

 

Our revenue was $1,440 and $38,792 for the six months ended June 30, 2026 and 2025, respectively, representing a decrease of 96%. For the six months ended June 30, 2026, revenue activity reflected the early commercialization of QuantrusX: the Company invoiced $28,064 to customers, recognized $1,440 as revenue during the period, and deferred the remaining $26,624 for future recognition ($9,128 current, $17,496 long-term) as the related performance obligations under the deployment are satisfied. For the six months ended June 30, 2025, revenue was derived from limited historical software and service activity under the Company’s prior positioning.

 

Operating Expenses

 

Our operating expenses were $3,694,220 and $5,921,491 for the six months ended June 30, 2026 and 2025, respectively, representing a decrease of 38%. The decrease was due to employee compensation including options, research and development expenses, marketing expenses and professional services provided to the Company.

 

Net Loss

 

Our net loss was $17,078,045 and $7,664,237 for the six months ended June 30, 2026 and 2025, respectively, representing an increase of 123%. The increase was mainly due to conversion of warrants, debt discount amortization, derivative expenses and loss from operations.

 

Liquidity and Capital Resources

 

As of June 30, 2026, the Company had an accumulated deficit of $57,916,272 and cash of $2,161,653 (including $1,913,320 of restricted cash). During the three months ended June 30, 2026 and 2025, we had a net loss of $11,049,252 and $3,130,592, respectively. To date, we have financed our operations primarily through revenue generated from sales of our securities.

 

Management has prepared estimates of operations and believes that sufficient funds will be generated from operations and equity financings to fund our operations and to service our debt obligations for at least the next twelve months. The Company has applied for an uplisting of its Class A Common Stock on NYSE American, upon approval of which certain restricted cash and additional committed capital would become available to fund operations. In addition, the Company maintains a Credit Facility providing up to $45.0 million of additional financing, subject to the terms and conditions thereof. Management believes that these sources, together with expected cash proceeds from executed and prospective QuantrusX subscription agreements, will be sufficient to fund planned operations for at least the next twelve months. However, availability of the listing-related amounts and the Credit Facility is subject to conditions not entirely within the Company’s control, and substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. In the future, we may require additional cash resources due to changing business conditions, implementation of our strategy to expand our business, or other investments or acquisitions we may decide to pursue. If our own financial resources are insufficient to satisfy our capital requirements, we may seek to sell additional equity or debt securities or obtain additional credit facilities. The sale of additional equity securities could result in dilution to our stockholders. The incurrence of indebtedness would result in increased debt service obligations and could require us to agree to operating and financial covenants that would restrict our operations. Financing may not be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable to us, or at all, could limit our ability to expand our business operations and could harm our overall business prospects.

 

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis under which we are expected to be able to realize our assets and satisfy our liabilities in the normal course of business.

 

Going Concern

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

 

6

 

 

While we had cash of $2,161,653 (including $1,913,320 of restricted cash) as of June 30, 2026, we had revenue of $1,440 and $38,792, a net loss of $17,078,045 and $7,664,237, and net cash used in operating activities of $1,812,972 and $2,278,896 for the six months ended June 30, 2026 and 2025, respectively. We have incurred losses since our inception, resulting in an accumulated deficit of $57,916,272 as of June 30, 2026, and further losses are anticipated in the development of our business.

 

The Company estimates that it will require approximately $4.0 million to fund operations for the twelve months following the issuance of these financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the financial statements are issued. Management has evaluated whether these conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued, as discussed below.

 

Management’s Plans

 

The Company has applied for an uplisting of its Class A Common Stock on NYSE American. Upon approval of such uplisting, a total of approximately $5.0 million will become available to the Company, consisting of (i) the release of the $1.9 million of restricted cash currently reflected on the Company’s balance sheet, and (ii) an approximate $3.0 million deposit to be made by an institutional investor (the “Investor”) pursuant to the executed securities purchase agreement between the Company and the Investor. Of the approximately $5.0 million, approximately $3.0 million will be immediately unrestricted and available for general corporate purposes, with the remainder becoming available upon satisfaction of the conditions set forth in the Investor agreements. In addition, the Company maintains a contingent financing facility with the Investor providing for up to $45.0 million of additional financing (the “Credit Facility”), pursuant to the securities purchase agreement and subject to the terms and conditions thereof, which management believes would be available to fund any shortfall in the Company’s working capital requirements.

 

In June 2026, the Company commenced commercial deployment of its QuantrusX edge intelligence platform. The Company’s commercial model provides for fixed-fee, prepaid multi-year subscription arrangements, under which contract consideration is collected at or near contract inception and recognized as revenue ratably over the subscription term. Accordingly, executed customer agreements generate cash proceeds in advance of revenue recognition. The Company executed its initial multi-year prepaid QuantrusX subscription agreement in June 2026 and maintains an active pipeline of prospective customers, which management expects to contribute to liquidity over the next twelve months.

 

The amounts becoming available upon uplisting are conditioned upon approval of the Company’s NYSE American listing application, which is not within the Company’s control, and availability under the Credit Facility is subject to conditions that may not be satisfied. There can be no assurance that the Company’s listing application will be approved, that amounts under the Credit Facility will be available when needed or on acceptable terms, or as to the timing or volume of future customer agreements. Accordingly, management has concluded that these plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Our ability to execute our business plan and achieve profitability is dependent upon our success in: (i) accessing the Credit Facility as planned, (ii) continuing to scale revenue growth, (iii) achieving operational efficiencies, and (iv) accessing additional capital as needed through securities offerings, private equity offerings, debt financings, strategic partnerships, and government or other third-party funding. These plans, if successful, will mitigate the factors which raise substantial doubt about our ability to continue as a going concern.

 

While we anticipate potential dilution from equity financings, management is committed to balancing growth capital needs with stockholder value creation. The Company maintains flexibility to optimize its capital structure through various financing alternatives based on market conditions and strategic priorities. Any failure by us to raise additional funds on terms favorable to us, or at all, could limit our ability to expand our business operations and could harm our overall business prospects.

 

There are uncertainties surrounding these issues, and the unaudited condensed consolidated financial statements do not reflect any changes regarding the recoverability or classification of asset values, nor do they address potential adjustments to the amounts or classification of liabilities that could arise if the Company cannot continue operating as a going concern.

 

7

 

 

Summary of Cash Flow

 

The following table provides detailed information about our net cash flow for the periods presented:

 

    Six Months Ended  
    June 30,  
    2026     2025  
Net cash used in operating activities   $ (1,812,972 )   $ (2,278,896 )
Net cash provided by (used in) investing activities     -       -  
Net cash provided by financing activities     1,951,553       2,027,932  
Net change in cash and cash equivalents     138,581       (250,964 )
Cash, cash equivalents and restricted cash at beginning of period     2,023,072       396,870  
Cash, cash equivalents and restricted cash at end of period   $ 2,161,653     $ 145,906  

 

Net cash used in operating activities was $1,812,972 and $2,278,896 for the six months ended June 30, 2026 and 2025, respectively. For the six months ended June 30, 2026, net cash used in operating activities resulted from a net loss of $17,078,045, stocks, options and warrants issued for various services of $1,917,290, notes payable discount amortization and loss on conversion of notes payable of $13,468,479, depreciation and amortization of $122,945, an increase in accounts receivable of $28,064, an increase in deferred revenue of $26,624, an increase in prepaid expenses of $849, an increase in ROU asset, net of $66,694, an increase in accounts payable and accrued expenses of $21,180, an increase in ROU liabilities of $67,870, and an increase in interest payable of $339,394. For the six months ended June 30, 2025, net cash used in operating activities resulted from a net loss of $7,664,236, stocks, options and warrants issued for various services of $3,667,533, notes payable discount amortization of $1,615,738, depreciation and amortization of $30,725, a decrease in prepaid expenses of $15,210, a decrease in accounts payable and accrued expenses of $95,595, and an increase in interest payable of $151,729.

 

Net cash provided by (used in) investing activities was $0 and $0 for the six months ended June 30, 2026 and 2025, respectively.

 

Net cash provided by financing activities was $1,951,553 and $2,027,932 for the six months ended June 30, 2026 and 2025, respectively. For the six months ended June 30, 2026, financing activities consisted of $1,980,000 in proceeds from notes payable, partially offset by $28,447 of principal and interest repayments on notes payable. For the six months ended June 30, 2025, financing activities consisted of $1,900,000 in proceeds from notes payable and $127,932 in proceeds from the Company’s Regulation A offering.

 

Contractual Obligations

 

During the six months ended June 30, 2026 and 2025, we had contractual obligations associated with management consultants in which we paid out $625,000 and $580,000, respectively.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

 

Critical Accounting Policies and Estimates

 

This discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. While our significant accounting policies are described in more detail in the notes to our financial statements included elsewhere in this prospectus, we believe that the following accounting policies are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates. We believe our most critical accounting policies and estimates relate to the following:

 

8

 

 

Principles of Consolidation

 

The Company’s unaudited condensed consolidated financial statements and related notes include all the accounts of the Company and its wholly owned subsidiaries. They have been prepared in accordance with U.S. GAAP. All intercompany transactions have been eliminated in consolidation.

 

Share-Based Compensation

 

ASC 718, “Compensation – Stock Compensation”, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the unaudited condensed consolidated financial statements based on their grant date fair values. That expense is recognized over the period when an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period) or the straight-line attribution method. Under 718-10-30-20D the determination of whether a valuation method is reasonable, or whether an application of a valuation method is reasonable, shall be made based on the facts and circumstances as of the measurement date.

 

Goodwill

 

We allocate goodwill to reporting units based on the reporting unit expected to benefit from the business combination. We evaluate our reporting units on an annual basis and, if necessary, reassign goodwill using a relative fair value allocation approach. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. These events or circumstances could include a significant change in the business climate, legal factors, operating performance indicators, competition, or sale or disposition of a significant portion of a reporting unit.

 

Application of the goodwill impairment test requires judgment, including the identification of reporting units, assignment of assets and liabilities to reporting units, assignment of goodwill to reporting units, and determination of the fair value of each reporting unit. The fair value of each reporting unit is estimated primarily through the use of a discounted cash flow methodology. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of our weighted average cost of capital.

 

The estimates used to calculate the fair value of a reporting unit change from year to year based on operating results, market conditions, and other factors. Changes in these estimates and assumptions could materially affect the determination of fair value and goodwill impairment for each reporting unit.

 

Revenue Recognition

 

The Company has adopted revenue recognition policies for its principal revenue types, including subscription and license fees, usage-based fees, professional and other services, and hardware. Prior to fiscal year 2026, the Company's revenue was derived from software license, hardware, and professional services activity. Beginning in the second quarter of 2026, the Company introduced QuantrusX, an edge intelligence platform, and revenue has since primarily consisted of QuantrusX subscription fees; other revenue streams described below have not been material during the periods presented. See Note 2 to the unaudited condensed consolidated financial statements.

 

9

 

 

Deferred revenue represents amounts invoiced or received from customers in advance of the Company satisfying its related performance obligations under ASC 606, Revenue from Contracts with Customers. Deferred revenue is recognized as revenue as the Company transfers control of the promised products or services to the customer. The current portion of deferred revenue represents amounts expected to be recognized as revenue within twelve months of the balance sheet date; the long-term portion represents amounts expected to be recognized beyond twelve months, based on the performance and delivery terms of the underlying contracts.

 

The Company determines the amount of revenue to be recognized through the application of the following steps:

 

identification of the contract, or contracts, with a customer;

 

identification of the performance obligations in the contract;

 

determination of the transaction price;

 

allocation of the transaction price to the performance obligations in the contract; and

 

recognition of revenue when or as the Company satisfies the performance obligations.

 

Recently Issued Accounting Pronouncements

 

Management does not believe any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed consolidated financial statements.

 

10

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

As a “smaller reporting company,” we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2026.

 

Changes in Internal Control Over Financial Reporting

 

During the period covered by this report there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on the Effectiveness of Controls

 

Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.

 

11

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business, financial condition, and results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

 

Item 1A. Risk Factors

 

As a “smaller reporting company,” we are not required to provide the information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Unregistered Sales of Equity Securities

 

During the three months ended June 30, 2026, we have conducted closings of an ongoing private placement of units, with each unit consisting of an unsecured 18% promissory note and a five-year warrant to purchase shares of Class A Common Stock, and entered into certain subscription agreements with a number of accredited investors as defined in Section 2(a)(15) of the Securities Act, and Rule 501 promulgated thereunder, in reliance upon the exemption contained in Section 4(a)(2) of the Securities Act, and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. Pursuant to the agreements, we sold 56.4 units at a price of $25,000 per unit for gross proceeds of $1,410,000 and issued 940,016 warrants with an exercise price of $1.50 per share.

 

Purchases of Equity Securities

 

No repurchases of our common stock were made during the three months ended June 30, 2026.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

We have no information to disclose that was required to be disclosed in a Current Report on Form 8-K during the three months ended June 30, 2026, but was not reported.

 

During the three months ended June 30, 2026, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.

 

12

 

 

Item 6. Exhibits

 

Exhibit No.   Description
3.1   Articles of Incorporation of Reticulate Micro, Inc. (incorporated by reference to Exhibit 2.1 to Form 1-A filed on May 24, 2024)
3.2   Amendment to Articles of Incorporation of Reticulate Micro, Inc. (incorporated by reference to Exhibit 2.2 to Form 1-A filed on May 24, 2024)
3.3   Certificate of Amendment to Articles of Incorporation of Reticulate Micro, Inc. (incorporated by reference to Exhibit 2.1 to Form 1-U filed on August 1, 2025)
3.4   Certificate of Change filed with the Secretary of State of the State of Nevada on July 22, 2026 (incorporated by reference to Exhibit 3.1 to Form 8-K filed on July 24, 2026)
3.5   Bylaws of Reticulate Micro, Inc. (incorporated by reference to Exhibit 3.3 to Form S-1 filed on October 23, 2023)
3.6   Amendment No. 1 to Bylaws of Reticulate Micro, Inc. (incorporated by reference to Exhibit 2.4 to Form 1-A filed on May 24, 2024)
3.7   Amendment No. 2 to Bylaws of RMX Industries, Inc. (incorporated by reference to Exhibit 2.2 to Form 1-U filed on April 2, 2026)
3.8   Certificate of Designation of Series X Convertible Preferred Stock of RMX Industries, Inc. (incorporated by reference to Exhibit 2.1 to Form 1-U filed on October 17, 2025)
3.9   Certificate of Amendment to Designation of Series X Convertible Preferred Stock of RMX Industries, Inc. (incorporated by reference to Exhibit 2.1 to Form 1-U filed on April 2, 2026)
4.1   Form of Private Placement Investor’s Warrant for January 2026 Private Placement (incorporated by reference to Exhibit 3.9 to Form 1-K filed on February 10, 2026)
4.2*   Form of Private Placement Investor’s Warrant for July 2026 Private Placement
10.1   Form of Private Placement Subscription Agreement for January 2026 Private Placement (incorporated by reference to Exhibit 6.62 to Form 1-K filed on February 10, 2026)
10.2   Form of Private Placement 18% Promissory Note for January 2026 Private Placement (incorporated by reference to Exhibit 6.63 to Form 1-K filed on February 10, 2026)
10.3   Intellectual Property Purchase Agreement, dated as of May 8, 2026, by and between RMX Industries, Inc. and Apollo Group Enterprises, LLC (incorporated by reference to Exhibit 10.3 to Form 8-K filed on May 14, 2026)
10.4*   Form of Private Placement Subscription Agreement for July 2026 Private Placement
10.5*   Form of Private Placement 18% Promissory Note for July 2026 Private Placement
31.1*   Section 302 Certification of Chief Executive Officer
31.2*   Section 302 Certification of Chief Financial Officer
32.1**   Section 906 Certification of Chief Executive Officer
32.2**   Section 906 Certification of Chief Financial Officer
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

* Filed herewith.
** The certifications attached as Exhibit 32.1 and 32.2 that accompanies this Quarterly Report on Form 10-Q, are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of RMX Industries, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

 

13

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  RMX Industries, Inc.
  (Registrant)
   
Dated: August 13, 2026 /s/ Karl Kit
  Karl Kit
  Chief Executive Officer, President, and Director
  (Principal Executive Officer)

 

  /s/ Amit Shrestha
  Amit Shrestha
  Chief Financial Officer
  (Principal Financial Officer and
  Principal Accounting Officer)

 

14


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

FORM OF PRIVATE PLACEMENT INVESTOR'S WARRANT FOR JULY 2026 PRIVATE PLACEMENT

FORM OF PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT FOR JULY 2026 PRIVATE PLACEMENT

FORM OF PRIVATE PLACEMENT 18% PROMISSORY NOTE FOR JULY 2026 PRIVATE PLACEMENT

CERTIFICATION

CERTIFICATION

CERTIFICATION

CERTIFICATION

XBRL SCHEMA FILE

XBRL CALCULATION FILE

XBRL DEFINITION FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: ea0301076-10q_rmxindus_htm.xml

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: R48.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json